Novartis and Incyte to trial Jakavi for Covid-19
Novartis, in alliance with Incyte, has announced plans to assess Jakavi (ruxolitinib) in a Phase III clinical trial to treat…

Novartis, in alliance with Incyte, has announced plans to assess Jakavi (ruxolitinib) in a Phase III clinical trial to treat…
Vertex Pharmaceutics has announced it has entered into a definitive agreement to acquire Semma Therapeutics for $950m. Semma is an…
ByThird Rock Ventures has launched Maze Therapeutics, a start-up focused on translating genetic insights into new medicines.
US-based conglomerate General Electric (GE) has entered into a definitive agreement to divest its Biopharma business to science and technology…
A new report by Cancer Research UK has concluded that a new drug payment system, dubbed an outcome-based payment (OBP),…
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) submitted by AbbVie for its investigational…
The Association of the British Pharmaceutical Industry (ABPI), a trade group representing drugmakers in the UK, has warned that patients…
Japan-based Taiho Pharmaceutical has signed an agreement to licence its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor candidate TAS6417…